NCT01108263 - Use of INTEGRA™ Flowable Wound Matrix to Manage Diabetic Foot Ulcers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions

DiabetesFoot Ulcer

Interventions

DRUG

INTEGRA™ Flowable Matrix (Collagen)

INTEGRA™ Flowable Wound Matrix is an advanced 3-D porous matrix comprised of granulated cross-linked bovine tendon collagen and glycosaminoglycan. It provides a scaffold for cellular invasion and capillary growth. The collagen and glycosaminoglycan mix is hydrated with saline and applied on the wound bed.

Trial Locations (1)

20007

Georgetown University Hospital, Washington D.C.